Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Mathias Sheila — Virpax Pharmaceuticals, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Mathias Sheila

Mathias Sheila

Chief Scientific Officer at Virpax Pharmaceuticals, Inc. · on record since Oct 3, 2023

Insider trading activity of Mathias Sheila

Transactions on record: 1; since Jan 31, 2024

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Jan 31, 2024

Figures computed from official regulatory filings — methodology.

Companies where Mathias Sheila has traded

Virpax Pharmaceuticals, Inc.1 tx · Jan 31, 2024

Track record of Mathias Sheila

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Mathias Sheila

Co-insiders of Mathias Sheila

Bruce Gerald WVirpax Pharmaceuticals, Inc.
Chaudhry UsamaVirpax Pharmaceuticals, Inc.
Chipman Christopher MichaelVirpax Pharmaceuticals, Inc.
Dhaliwal JatinderVirpax Pharmaceuticals, Inc.
Dubin Michael FVirpax Pharmaceuticals, Inc.
Field KatharynVirpax Pharmaceuticals, Inc.
Floyd EricVirpax Pharmaceuticals, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Gudin JeffreyVirpax Pharmaceuticals, Inc.

Herman Gary LVirpax Pharmaceuticals, Inc.

JACOB GARY SVirpax Pharmaceuticals, Inc.

Jambulingam ThaniVirpax Pharmaceuticals, Inc.

Mack Anthony P.Virpax Pharmaceuticals, Inc.

Panis JaydrianeVirpax Pharmaceuticals, Inc.

Randhawa EshaVirpax Pharmaceuticals, Inc.

Ruskin BarbaraVirpax Pharmaceuticals, Inc.

Sendrow JerroldVirpax Pharmaceuticals, Inc.

Shah VinayVirpax Pharmaceuticals, Inc.

Singh VanilaVirpax Pharmaceuticals, Inc.

Su JudyVirpax Pharmaceuticals, Inc.

Virpax Pharmaceuticals LLCVirpax Pharmaceuticals, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Virpax Pharmaceuticals, Inc.	Jan 31, 2024	AwardD	112,000	0.00 USD	$0	SEC